Definium Therapeutics Us, Inc.

This phase 3 study tests whether an oral medication called MM120 can reduce anxiety symptoms in adults with generalized anxiety disorder (GAD). About 250 participants will receive either MM120 or a placebo for 12 weeks, followed by a 40-week period where everyone can receive MM12…

This phase 3 study tests an oral medication called MM120 against a placebo in 149 adults with major depressive disorder. Participants take the drug or placebo for 12 weeks, followed by a 40-week period where everyone can receive MM120. The main goal is to see if MM120 reduces dep…

This study tests an oral medication called MM120 against a placebo in 214 adults with generalized anxiety disorder. The first 12 weeks are double-blind (neither you nor the doctor knows which group you're in), followed by a 40-week period where everyone can receive MM120. The mai…